- Home
- SNDR vs ADMA Comparison
SNDR vs ADMA Comparison
Compare SNDR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDR
- ADMA
- Stock Information
- Founded
- SNDR 1935
- ADMA 2004
- Country
- SNDR United States
- ADMA United States
- Employees
- SNDR N/A
- ADMA N/A
- Industry
- SNDR Trucking Freight/Courier Services
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNDR Industrials
- ADMA Health Care
- Exchange
- SNDR Nasdaq
- ADMA Nasdaq
- Market Cap
- SNDR 4.5B
- ADMA 5.1B
- IPO Year
- SNDR 2017
- ADMA N/A
- Fundamental
- Price
- SNDR $25.62
- ADMA $17.14
- Analyst Decision
- SNDR Buy
- ADMA Strong Buy
- Analyst Count
- SNDR 14
- ADMA 3
- Target Price
- SNDR $27.64
- ADMA $27.67
- AVG Volume (30 Days)
- SNDR 917.0K
- ADMA 2.6M
- Earning Date
- SNDR 07-31-2025
- ADMA 08-07-2025
- Dividend Yield
- SNDR 1.49%
- ADMA N/A
- EPS Growth
- SNDR N/A
- ADMA N/A
- EPS
- SNDR 0.71
- ADMA 0.84
- Revenue
- SNDR $5,373,300,000.00
- ADMA $459,381,000.00
- Revenue This Year
- SNDR $10.61
- ADMA $21.42
- Revenue Next Year
- SNDR $6.24
- ADMA $26.30
- P/E Ratio
- SNDR $35.99
- ADMA $20.50
- Revenue Growth
- SNDR N/A
- ADMA 62.23
- 52 Week Low
- SNDR $20.59
- ADMA $10.21
- 52 Week High
- SNDR $33.90
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- SNDR 54.41
- ADMA 37.91
- Support Level
- SNDR $24.80
- ADMA $16.50
- Resistance Level
- SNDR $25.78
- ADMA $18.79
- Average True Range (ATR)
- SNDR 0.69
- ADMA 0.63
- MACD
- SNDR -0.11
- ADMA -0.04
- Stochastic Oscillator
- SNDR 28.15
- ADMA 30.63
About SNDR Schneider National Inc.
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.